Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2003
03/26/2003EP1294753A2 A human homologue of the db4/ask1 protein, nucleic acids, and methods related to the same
03/26/2003EP1294752A2 Angiogenesis-modulating compositions and uses
03/26/2003EP1294751A1 Dermacentor variabilis gaba-gated chloride channels
03/26/2003EP1294750A2 Acid-modified arabinogalactan protein composition
03/26/2003EP1294749A2 Use of recombinant antigens to determine the immune status of an animal
03/26/2003EP1294748A2 Single chain class i major histo-compatibility complexes, constructs encoding same and methods of generating same
03/26/2003EP1294746A1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains
03/26/2003EP1294744A2 Peptides that stimulate cell survival and axon regeneration
03/26/2003EP1294743A2 Method of obtaining peptides with tissue-specific activity and pharmaceutical compositions on their basis
03/26/2003EP1294738A2 Novel motor proteins and methods for their use
03/26/2003EP1294472A1 Electrophoresis separation and treatment of samples
03/26/2003EP1294409A2 Membrane-permeant peptide complexes for medical imaging
03/26/2003EP1294406A2 Modulation of chromosome function by chromatin remodeling agents
03/26/2003EP1294400A1 Vaccine against foot-and-mouth disease
03/26/2003EP1294391A2 Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking lfa-1 mediated adhesion
03/26/2003EP1294386A1 Synthetic oxygen transport made from cross-linked modified human or porcine haemoglobin with improved properties, method for a preparation thereof from purified material and use thereof
03/26/2003EP1294227A2 Transgenic mice containing nuclear hormone receptor gene disruptions
03/26/2003EP1165755A4 Banana and melon promoters for expression of transgenes in plants
03/26/2003EP1150701A4 Homing pro-apoptotic conjugates and methods of using same
03/26/2003EP1141269A4 Secreted proteins and uses thereof
03/26/2003EP1112096B1 Collagenous tissue compositions
03/26/2003EP1091948B1 Tubulin binding compounds (cobra)
03/26/2003EP1064012A4 Enhancement of the pro-fertility action of a molecule involved in sperm-egg binding
03/26/2003EP1012184A4 Derivatives of growth hormone and related proteins
03/26/2003EP1005483A4 Methods and compositions for rapid furification of proteasomes and methods of use of components thereof
03/26/2003EP0994898B1 Integrin binding peptide and use thereof
03/26/2003EP0976331B1 Soybean protein hydrolysates, their production and use
03/26/2003EP0956038B1 Morphogen peptide-induced regeneration of sense perceptory tissues
03/26/2003EP0950063B1 Multiple branch peptide constructions
03/26/2003EP0939809B1 Tie-2 receptor ligand (tie ligand-4) and its use
03/26/2003EP0900383B1 Peptides having specific affinity to pacap type 1 receptors
03/26/2003EP0835261B1 Ion channel
03/26/2003EP0833658B1 Inhibin compositions and methods of enhancing production performance
03/26/2003EP0831867B1 Collagen-based delivery matrix
03/26/2003EP0759037B1 Antigen/antibody specificity exchanger
03/26/2003EP0625159B1 Ikaros: a regulatory gene involved in t-cell differentiation
03/26/2003EP0610436B9 Hepatitis-c virus testing
03/26/2003EP0431128B1 Vector coding for self-assembled, defective, non-self-propagating viral particles
03/26/2003EP0261224B2 Synthetic htlv-iii peptides, compositions and uses thereof
03/26/2003CN1406284A Immunoassay and diagnostic reagent for malaria
03/26/2003CN1406280A Progenitor cell preservation factors and related methods and products
03/26/2003CN1406278A Expression of recombinant mature lysostaphin
03/26/2003CN1406277A Recombinant attenuation of PRRSV
03/26/2003CN1406276A Sericin-containing material, Process for producing the same and method of using the same
03/26/2003CN1406249A Enhancing the circulating half-life of antibody-based fusion proteins
03/26/2003CN1406247A Method of monomerizing human serum albumin polymers
03/26/2003CN1406246A Method of producing human albumin involving heating step
03/26/2003CN1406245A Method of eliminating human serum albumin polymers
03/26/2003CN1406244A Compounds for detection of infection by chlamydophila abortus
03/26/2003CN1406136A Novel antibody with specificity for colon cancer
03/26/2003CN1406108A Method for lowering pollen fertility by using tapetal layer-specific zinc finger transcriptional factor gene
03/26/2003CN1405311A Cnidarian cytotoxin gene and its expression and application
03/26/2003CN1405310A Method for producing medicine using silkworm expressed numan epidermal growth factor
03/26/2003CN1405309A Method for preparing medicine using silkworm expressed human beta interferon
03/26/2003CN1405308A Method for producing medicine using silkworm expressed human alpha2b interferon
03/26/2003CN1405298A Yeast recombinant strain and IFN alpha-2b interferon purifying method
03/26/2003CN1405183A Serum albumin and granulocyte-macrophage colony stimulating factor fusion protein
03/26/2003CN1405182A 血清白蛋白与粒细胞集落刺激因子的融合蛋白 Serum albumin and granulocyte colony-stimulating factor fusion protein
03/26/2003CN1405181A Serum albumin and interferon fusion protein
03/26/2003CN1405180A Chemotactic factor beta-8 short type
03/26/2003CN1405174A Housefly phylaxin gene, and its cloning method and recombinant application
03/26/2003CN1405150A Protein modifier, preparation method and use thereof
03/26/2003CN1103812C Human beta-2 integrin alpha subunit
03/26/2003CN1103782C Mono-pegylated MGDF polypeptide
03/26/2003CN1103781C Abundant extracellular product and methods for production and use of same
03/26/2003CN1103602C Process for preparing pharmaceutical formulation containing insulin analog
03/26/2003CA2423858A1 Novel proteins, genes encoding them and method of using the same
03/25/2003USRE38046 (delayed type sensitivity) DTH-Effector cells are printed with carbohydrate antigens; antitumor
03/25/2003US6538182 Genetic modification of plants to control age-related or environmental stress-induced senescence; use in extending shelf-life and slowing spoilage of plant cuttings, flowers, seeds, fruits, vegatables, or leaves
03/25/2003US6538176 In the genetic manipulation of plants, particularly to modulating DNA metabolism in transformed plants and plant cells
03/25/2003US6538175 Method for selecting disease resistant plants by marker assisted selection techniques; use in identifying quantitative trait loci associated with nematode resistance in plants
03/25/2003US6538127 Synthetic HIV-2 envelope genes containing modifications that lead to optimized expression in bacteria
03/25/2003US6538126 Polynucleotides of given sequence derived from CDNA
03/25/2003US6538125 Insertion sequence element derived from Ralstonia solanacearum
03/25/2003US6538123 Vaccine composition for preventing or treating hepatitis C
03/25/2003US6538121 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
03/25/2003US6538120 Genomic sequence of the human μ-opioid receptor gene and the variants, polymorphisms and mutations thereof
03/25/2003US6538119 Nucleotide sequences for use in the classification, diagnosis, prevention, imaging and treatment of mammary gland defects
03/25/2003US6538118 Expression of lipoproteins
03/25/2003US6538113 Methods of obtaining antibody directed against prothrombin fragments F2/F1+2
03/25/2003US6538111 Monoclonal, humanized antibodies; hybridomas; transformants; use in diagnosis and treatment of chronic bronchial asthma
03/25/2003US6538109 Polynucleotide compositions encoding broad spectrum delta-endotoxins
03/25/2003US6538108 Compositions and methods relating to DNA mismatch repair genes
03/25/2003US6538107 G protein coupled receptor protein production, and use thereof
03/25/2003US6538106 Compositions and methods for treating infections using analogues of indolicidin
03/25/2003US6538104 Stabilization of cardiac troponin I subunits and complexes
03/25/2003US6538103 Anti-angiogenic agents; kringle 1; use treatment of cancer, diabetic retinopathy, rheumatoid arthritis, psoriasis, arteriosclerotic plaque formation
03/25/2003US6537972 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
03/25/2003US6537967 Treating human immunodeficiency virus infections
03/25/2003US6537966 Follistatin-3
03/25/2003US6537965 Novel parathyroid hormone (PTH) peptide derivatives. In particular, the invention relates to PTH PTH-2 receptor agonist or antagonist properties to the derivatives.
03/25/2003US6537815 Method of altering the expression of csrB to modify the properties of a cell
03/25/2003US6537810 Methods for regulating T cell subsets by modulating transcription factor activity
03/25/2003US6537804 Expression vector comprising a DNA sequence that expresses a peptide of given amino acid sequence which includes tyrosine; use in diagnosis and treatment of leukemia
03/25/2003US6537803 Produced by a recombinant expression vector in a cell; use in pharmacology and drug screening
03/25/2003US6537794 Chemokine
03/25/2003US6537786 Genes encoding exopolysaccharide production
03/25/2003US6537784 Self-regulated apoptosis of inflammatory cells by gene therapy
03/25/2003US6537781 Methods and compositions concerning canine interleukin 5
03/25/2003US6537778 Eukaryotic mechanosensory transduction channel